Cleo vs Alteryx
Detailed side-by-side comparison to help you choose the right tool
Cleo
Automation & Workflows
AI-powered clinical decision support platform for acute care hospitals, providing real-time patient deterioration detection, sepsis prediction, and workflow optimization to improve outcomes and reduce clinician burnout.
Was this helpful?
Starting Price
CustomAlteryx
Automation & Workflows
Enterprise data analytics platform for automating data workflows and generating AI-powered business insights through advanced data preparation and predictive modeling.
Was this helpful?
Starting Price
CustomFeature Comparison
Scroll horizontally to compare details.
Cleo - Pros & Cons
Pros
- ✓Aims to consolidate deterioration detection, sepsis prediction, and capacity management into a single acute-care-focused platform, potentially reducing the need to procure and integrate multiple point solutions
- ✓Claims direct integration into existing EHR workflows (Epic, Cerner) so clinicians don't need to learn a separate application
- ✓Configurable alert sensitivity reportedly allows clinical informatics teams to tune the system to their facility's tolerance for alert fatigue
- ✓Describes explainable risk scores showing contributing factors, which if validated would enable clinicians to make informed decisions rather than relying on black-box outputs
- ✓Covers multiple acute care use cases within a single platform, unlike competitors that typically specialize in one domain (imaging, operations, or sepsis scoring alone)
Cons
- ✗Independent verification of the product, its customer base, and clinical outcomes is extremely limited — no peer-reviewed studies, named references, or specific outcome data are publicly available
- ✗Enterprise-only pricing (estimated at $50,000+/year based on comparable platforms) makes it inaccessible for small or rural hospitals without dedicated AI budgets
- ✗As a newer entrant, Cleo lacks the established install base and track record of competitors like Qventus, Viz.ai, or Epic's native tools, increasing procurement risk
- ✗Implementation requires a multi-week integration and calibration period, which may delay time-to-value by 2–3 months
- ✗Limited to acute care settings — organizations looking for outpatient, primary care, or population health AI will need a separate solution
- ✗FDA clearance status is not publicly documented, and no clinical validation studies are available in public databases such as PubMed
Alteryx - Pros & Cons
Pros
- ✓Low-code drag-and-drop interface lets analysts build complex ETL and ML workflows without Python or SQL expertise
- ✓Comprehensive tool palette with 300+ pre-built tools covering data prep, blending, spatial analytics, and predictive modeling
- ✓AiDIN generative AI layer (launched 2023, expanded in 2024-2025) adds Magic Documents, Workflow Summary, and the Aria assistant for workflow authoring
- ✓Strong governance and audit trail features through Alteryx Server, valued in regulated industries like finance and healthcare
- ✓Mature ecosystem with 8,000+ enterprise customers, an active community of 500,000+ users, and a marketplace of pre-built macros
- ✓Tight integrations with Snowflake, Databricks, AWS, and Azure for in-database processing at scale
Cons
- ✗Premium pricing — Designer licenses historically start around $5,195/user/year, putting it out of reach for small teams and individuals
- ✗Steeper learning curve than BI tools like Tableau or Power BI for first-time users despite the low-code branding
- ✗Desktop Designer is Windows-only, limiting Mac and Linux users to the cloud version
- ✗Workflow performance can degrade with very large datasets unless paired with in-database tools or Snowflake/Databricks pushdown
- ✗Licensing model and feature gating across Designer, Server, and Analytics Cloud can be confusing during procurement
Not sure which to pick?
🎯 Take our quiz →🦞
🔔
Price Drop Alerts
Get notified when AI tools lower their prices
Get weekly AI agent tool insights
Comparisons, new tool launches, and expert recommendations delivered to your inbox.